AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MEDICAL
Mylan, King end $4 bil merger
The generic drug maker and the branded drug maker called off their planned all-stock merger, saying they couldn't agree on terms. Mylan had begun negotiating new terms for the takeover after King Pharmaceuticals said it would restate earnings for '02, '03 and the first half of '04. King fell 7% to 9.55, while Mylan rose 4% to 17.60.
Martek confirms Kellogg deal
The biotech, which had announced a supply agreement with a "Fortune 500 food company" on Feb. 4, ...